查看购物车
  • Traditional Chinese
  • English
  • Japanese
HIV 护理点 (POC) 检测市场：管道报告（发展阶段、细分市场、地区/国家、监管途径、主要参与者）
市场调查报告书
商品编码
1398311

HIV 护理点 (POC) 检测市场：管道报告（发展阶段、细分市场、地区/国家、监管途径、主要参与者）

HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
出版日期: | 出版商: GlobalData | 英文 109 Pages | 订单完成后即时交付

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

HIV 护理点 (POC) 测试被定义为在患者接受治疗的地方附近、临床实验室之外进行的医学诊断测试。 POC 通常由临床实验室以外的人员执行，结果用于临床决策。 POC 的复杂性和程序各不相同，从手动技术到自动分析仪。 POC 仪器通常是 "手持式" 的，并且可能是小型便携式分析设备。

本报告检视了 HIV 即时照护 (POC) 检测市场，提供产品概述、正在开发的管道产品趋势、不同开发阶段产品的比较分析以及正在进行的临床试验的资讯。我们提供资讯关于参与公司的最新趋势。

目录

第 1 章目录

第 2 章简介

  • HIV 即时检测 (POC) 检测概述

第三章开发中的产品

  • HIV 即时护理 (POC) 检测 - 按开发阶段划分的管道产品
  • HIV 护理点 (POC) 检测 - 按地区划分的在研产品
  • HIV 护理点 (POC) 检测 - 按监管途径划分的管道产品
  • HIV 护理点 (POC) 检测 - 管道产品（按预计批准日期）
  • HIV 护理点 (POC) 检测 - 正在进行的临床试验

第 4 章 HIV 照护点 (POC) 检测 - 公司正在开发的管道产品

  • HIV 护理点 (POC) 检测公司 - 按开发阶段划分的管道产品
  • HIV 护理点 (POC) 测试 - 按开发阶段划分的管道产品

第五章 HIV 即时检测 (POC) 检测公司与产品概述

第 6 章 HIV 照护点 (POC) 检测 - 最新进展

第七章附录

  • 调查方法
  • 关于环球数据
  • 联络我们
  • 免责声明

Abstract

GlobalData's Medical Devices sector report, "HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the HIV Point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

HIV Point of care (POC) Tests is defined as medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care. POC is typically performed by non-laboratory personnel and the results are used for clinical decision making. POC has a range of complexity and procedures that vary from manual methodologies to automated analyzers. POC devices are often 'handheld' or may be small portable analyzers.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the HIV Point of care (POC) Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of HIV Point of care (POC) Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of HIV Point of care (POC) Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 HIV Point of care (POC) Tests Overview

3 Products under Development

  • 3.1 HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
  • 3.2 HIV Point of care (POC) Tests - Pipeline Products by Territory
  • 3.3 HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
  • 3.4 HIV Point of care (POC) Tests - Pipeline Products by Estimated Approval Date
  • 3.5 HIV Point of care (POC) Tests - Ongoing Clinical Trials

4 HIV Point of care (POC) Tests - Pipeline Products under Development by Companies

  • 4.1 HIV Point of care (POC) Tests Companies - Pipeline Products by Stage of Development
  • 4.2 HIV Point of care (POC) Tests - Pipeline Products by Stage of Development

5 HIV Point of care (POC) Tests Companies and Product Overview

6 HIV Point of care (POC) Tests- Recent Developments

  • 6.1 Oct 10, 2023: Trinity Biotech Welcomes the Decision of the High Court of Kenya to Strike Out the Applications to Prevent the Procurement of Trinscreen HIV by the Kenyan Ministry of Health
  • 6.2 Sep 27, 2023: Update on MedMira's Regulatory Path in Canada and the USA
  • 6.3 Jun 14, 2023: Atomo and Newfoundland Sign Agreement for HIV Testing in Europe
  • 6.4 Mar 22, 2023: Trinity Biotech welcomes TrinScreen HIV's inclusion in the New Kenyan HIV Testing Algorithm
  • 6.5 Feb 28, 2023: Significant purchase order for HIV self-tests for Europe

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
  • HIV Point of care (POC) Tests - Pipeline Products by Territory
  • HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
  • HIV Point of care (POC) Tests - Pi

List of Figures

List of Figures

  • HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
  • HIV Point of care (POC) Tests - Pipeline Products by Territory
  • HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
  • HIV Point of care (POC) Tests - P